Liver transplantation for homozygous familial hypercholesterolemia: Cure for a genetic disease?

Current Treatment Options in Homozygous Familial Hypercholesterolemia

(2023) Meral Kayikcioglu et al.   Pharmaceuticals

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

(2023) Marina Cuchel et al.   EUROPEAN HEART JOURNAL

Gene Therapy Targeting PCSK9

(2022) Julius L. Katzmann et al.   Metabolites

Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases

(2022) Mohammed Al Dubayee et al.   ADVANCES IN THERAPY

Lipoproteinapherese

(2022) Adrienn Tünnemann-Tarr et al.   HERZ

Cutaneous manifestations in familial hypercholesterolaemia

(2021) Julius L. Katzmann et al.   ATHEROSCLEROSIS

Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysis

(2021) Latifah Alothman et al.   Journal of Clinical Lipidology

Evinacumab for Homozygous Familial Hypercholesterolemia

(2020) Frederick J. Raal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel therapies for familial hypercholesterolemia

(2020) Farzahna Mohamed et al.   Current Opinion in Endocrinology Diabetes and Obesity

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

(2012) Marina Cuchel et al.   LANCET

Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy

(2011) Frederick J. Raal et al.   CIRCULATION